Did you know that the intersection of mental health and cutting-edge technology is paving the way for revolutionary therapies that could redefine our approach to mental health and wellness?

Imagine a future where AI and novel therapies like psychedelics work together to unlock new realms of mental health treatment. Matias Serebrinsky and Psymed Ventures are at the forefront of this innovation, not just envisioning it—they're actively shaping it.

Tune in to explore the new horizons of mental health!

🎙️ What's in the Episode:
1️⃣ Mental Health Reimagined: He discusses the urgent need for innovative solutions in a world where mental health issues are a growing concern.
2️⃣ The Investment in Innovation: Discover how Psymed Ventures is not just a fund—it's a visionary platform that brings together groundbreaking research and entrepreneurial spirit to transform mental health care.
3️⃣ The Revolutionary Potential of Psychedelics: He shares insights into the promising future of psychedelic therapy, AI's role in personalized care, and how these could drastically improve outcomes for patients worldwide.

👨‍💼 About Matias Serebrinsky:
He isn't just an investor; he's a catalyst for change. A passion has marked his journey from Argentina to Silicon Valley for disruptive technologies. As the force behind Psymed Ventures, Matias leverages his expertise in AI and his entrepreneurial background to champion a new era of mental health treatments that prioritize healing and holistic care. His philosophy is simple yet profound: invest in solutions that heal the mind and uplift humanity.

🎥 Don't miss this compelling episode where we delve into the future of mental health. Tune in now to understand how to join this mental health revolution.

💡 LINKS TO MORE CONTENT
Christian Soschner
Matias Serebrinsky

📌 Quotes:
(00:06:29) I'm keeping my Nvidia shares because Jensen is a once-in-a-generation type of founder, and you never want to bet against someone like that.
(00:20:10) Mental health disorders are rapidly becoming the largest burden of disease for society, more costly than cancer and cardiovascular disease.
(00:52:51) Psychedelics like iboga are being explored for opioid use disorder, showing significant effectiveness in initial studies.
(01:07:13) Psychedelics can alleviate the lack of therapy supply. Comparing 40 hours of psychedelic therapy to 150 hours of traditional therapy shows where the equation makes more sense.
(01:18:34) Some universities have streamlined the process, incentivizing professors to out-license or spin-out companies.

⏰ Timestamps:
(00:02:15) Insights on Nvidia and Investment Strategy
(00:05:53) Visionary Leadership: Nvidia's Strategic Shift to AI
(00:09:00) Matias’ Journey from Argentina to Psymed Ventures
(00:17:32) Veritas Health: A $2 Billion Success in Metabolic Dysfunction Treatment
(00:19:37) Reducing Mental Health Stigma and Addressing Growing Needs in Society
(00:33:56) Exploring Innovative Business Models in Mental Health Investment
(00:41:43) Interventional Psychiatry: Revolutionizing Mental Health Treatment with Psychedelics
(00:48:41) The Therapeutic Mystery of Psychedelics in Mental Health
(00:52:51) Exploring Psychedelics for Addiction Treatment: Beyond Traditional Methods
(01:06:41) Psychedelic Therapy: A New Paradigm in Mental Health
(01:15:24) Innovating Mental Health Treatment: Neurostimulation at Home

Send us a Text Message.

Support the Show.

Join the Podcast Newsletter: Link